Effect of zinc supplementation in patients with ulcerative colitis

Not Applicable

• Conditions: lcerative Colits; C06.405.205.731

• Registration Number: RBR-5yrjrr4
• Lead Sponsor: REGINA MÁRCIA SOARES CAVALCANTE

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-11-12
• Study Start: 2021-09-17
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Data analysis completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients diagnosed with ulcerative colitis (with at least 6 months of diagnosis time);non-smokers; without coexisting pathologies such as diabetes; hypertension and kidney disease;cardiovascular diseases; rheumatic diseases and any other diseases involving an inflammatory process; without the use of a vitamin-mineral supplement; who voluntarily agreed to participate in the research, with the consent materialized by signing the Informed Consent Term.

Exclusion Criteria

Patients who changed city and/or state; who did not have telephone contact;who discontinued use of the supplement; who did not attend the collection of biological material

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Supplementation with zinc gluconate recovered the nutritional status of patients in relation to the mineral, however there was no correlation between plasma and erythrocyte zinc levels and the cytokines analyzed (IL-2, IL-4, IL-6, IL-10 , IFN-? and TNF-a) at any time of supplementation.